Literature DB >> 9988744

Engineering the substrate specificity of the Abl tyrosine kinase.

J H Till1, P M Chan, W T Miller.   

Abstract

c-Abl is a non-receptor tyrosine kinase that is involved in a variety of signaling pathways. Activated forms of c-Abl are associated with some forms of human leukemia. Presently, no high resolution structure of the tyrosine kinase domain of Abl is available. We have developed a structural homology model of the catalytic domain of Abl based on the crystal structure of the insulin receptor tyrosine kinase. Using this model as a guide, we selected residues near the active site predicted to play a role in peptide/protein substrate recognition. We expressed and purified 15 mutant forms of Abl with single amino acid substitutions at these positions and tested their peptide substrate specificity. We report here the identification of seven residues involved in recognition of the P-1, P+1, and P+3 positions of bound peptide substrate. Mutations in these residues cause distinct changes in substrate specificity. The results suggest features of Abl substrate recognition that may be relevant to related tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988744     DOI: 10.1074/jbc.274.8.4995

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  KINATEST-ID: a pipeline to develop phosphorylation-dependent terbium sensitizing kinase assays.

Authors:  Andrew M Lipchik; Minervo Perez; Scott Bolton; Vasin Dumrongprechachan; Steven B Ouellette; Wei Cui; Laurie L Parker
Journal:  J Am Chem Soc       Date:  2015-02-17       Impact factor: 15.419

Review 2.  Differential signaling of Flt3 activating mutations in acute myeloid leukemia: a working model.

Authors:  Perry M Chan
Journal:  Protein Cell       Date:  2011-02-25       Impact factor: 14.870

Review 3.  ABL tyrosine kinases: evolution of function, regulation, and specificity.

Authors:  John Colicelli
Journal:  Sci Signal       Date:  2010-09-14       Impact factor: 8.192

4.  c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage.

Authors:  Kiyotsugu Yoshida; Kiyoshi Komatsu; Hong-Gang Wang; Donald Kufe
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

5.  Autoinhibition of the kit receptor tyrosine kinase by the cytosolic juxtamembrane region.

Authors:  Perry M Chan; Subburaj Ilangumaran; Jose La Rose; Avijit Chakrabartty; Robert Rottapel
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

6.  Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation.

Authors:  Zehavit Goldberg; Ronit Vogt Sionov; Michael Berger; Yaara Zwang; Ruth Perets; Richard A Van Etten; Moshe Oren; Yoichi Taya; Ygal Haupt
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

7.  Rational Redesign of a Functional Protein Kinase-Substrate Interaction.

Authors:  Catherine Chen; Wutigri Nimlamool; Chad J Miller; Hua Jane Lou; Benjamin E Turk
Journal:  ACS Chem Biol       Date:  2017-03-29       Impact factor: 5.100

8.  Fine-tuning of substrate preferences of the Src-family kinase Lck revealed through a high-throughput specificity screen.

Authors:  Neel H Shah; Mark Löbel; Arthur Weiss; John Kuriyan
Journal:  Elife       Date:  2018-03-16       Impact factor: 8.140

Review 9.  The Src module: an ancient scaffold in the evolution of cytoplasmic tyrosine kinases.

Authors:  Neel H Shah; Jeanine F Amacher; Laura M Nocka; John Kuriyan
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-09-05       Impact factor: 8.250

10.  Structural basis for the recognition of c-Src by its inactivator Csk.

Authors:  Nicholas M Levinson; Markus A Seeliger; Philip A Cole; John Kuriyan
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.